Metoprolol Tartrate NDC 72888-197

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-197Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0197Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72888-197-00	72888019700	1000 TABLET in 1 BOTTLE (72888-197-00)Marketed from Aug 28, 2025
72888-197-03	72888019703	60 TABLET in 1 BOTTLE (72888-197-03)Marketed from Jan 25, 2026
72888-197-30	72888019730	30 TABLET in 1 BOTTLE (72888-197-30)Marketed from Aug 28, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Metoprolol Tartrate
Generic name (nonproprietary): metoprolol tartrate
Active ingredients: Metoprolol tartrate — 12.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Advagen Pharma Limited
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 218698
Marketing start: Aug 28, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 72888-197_4984fefe-6924-2aa6-e063-6394a90a1853SPL ID 4984fefe-6924-2aa6-e063-6394a90a1853SPL set ID d62a972a-bc45-4582-9701-bed27a1a9e4dRxCUI 2723025UNII W5S57Y3A5LUPC 0372888197302, 0372888197005
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888019700 followed by a unit qualifier and the quantity

Package 72888-0197-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2026.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Metoprolol Tartrate Tablets is a beta-adrenergic blocker indicated in the treatment of hemodynamically stable adult patients with myocardial infarction, to reduce the risk of cardiovascular mortality. ( 1.1 ) 1.1 Myocardial Infarction Metoprolol Tartrate Tablets is indicated in the treatment of hemodynamically stable adult patients with myocardial infarction (MI) to reduce cardiovascular mortality.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 218698

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 218698
Product	Strength	Form · route	Labeler	Product NDC
Lopressormetoprolol tartrate	Metoprolol tartrate 12.5 mg/1	TabletOral	VALIDUS PHARMACEUTICALS LLC	30698-460